TRIM29 promoted cancer cell proliferation in vitro and enhanced tumor growth and metastasis in vivo, which was correlated with elevated beta-catenin levels in pancreatic cancer, and beta-catenin function was required for TRIM29's oncogenic effects [14]. Here, CTNNB1 is linked to familial pancreatic carcinoma.